Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Comcast
CMCSA
|
+$1.97B |
| 2 |
Burlington
BURL
|
+$1.07B |
| 3 |
Philip Morris
PM
|
+$759M |
| 4 |
General Motors
GM
|
+$673M |
| 5 |
JPMorgan Chase
JPM
|
+$666M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$2.75B |
| 2 |
Netflix
NFLX
|
+$1.61B |
| 3 |
Mercado Libre
MELI
|
+$1.12B |
| 4 |
Illumina
ILMN
|
+$1.05B |
| 5 |
Amazon
AMZN
|
+$974M |
Sector Composition
| 1 | Technology | 19.95% |
| 2 | Healthcare | 19.04% |
| 3 | Communication Services | 14.79% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ferrari
RACE
$85.3B
| $20.1M | 0.01% |
110,000
| – | – |
|
|
LOMA
377
Loma Negra
LOMA
$880M
| $19.9M | 0.01% |
4,612,282
| – | – |
|
378
Hilltop Holdings
HTH
$2.14B
| $15.4M | ﹤0.01% |
750,000
| – | – |
|
379
Graham Holdings Company
GHC
$5.06B
| $13.7M | ﹤0.01% |
34,000
-16,000
| -32% | -$6.47M |
|
380
Oneok
OKE
$45.7B
| $13M | ﹤0.01% |
498,608
| – | – |
|
381
Moelis & Co
MC
$5.52B
| $10.5M | ﹤0.01% |
300,000
-990,034
| -77% | -$34.8M |
|
382
Artivion
AORT
$1.88B
| $8.92M | ﹤0.01% |
483,112
-2,464,878
| -84% | -$45.5M |
|
|
HUIZ
383
Huize Holding Ltd
HUIZ
$35.6M
| $8.4M | ﹤0.01% |
210,000
| – | – |
|
384
StepStone Group
STEP
$4.78B
| $7.37M | ﹤0.01% |
+276,856
| New | +$7.37M |
|
385
Cardlytics
CDLX
$67.6M
| $7.06M | ﹤0.01% |
+100,000
| New | +$7.06M |
|
386
Outset Medical
OM
$244M
| $6.41M | ﹤0.01% |
+8,540
| New | +$6.41M |
|
387
Asana
ASAN
$3.17B
| $6.36M | ﹤0.01% |
+235,600
| New | +$6.36M |
|
388
ASML
ASML
$341B
| $5.81M | ﹤0.01% |
15,649
-29,458
| -65% | -$10.9M |
|
|
AMED
389
DELISTED
Amedisys
AMED
| $4.07M | ﹤0.01% |
17,200
| – | – |
|
390
NMI Holdings
NMIH
$3.03B
| $4.06M | ﹤0.01% |
228,075
| – | – |
|
391
Walt Disney
DIS
$208B
| $2.03M | ﹤0.01% |
16,358
| – | – |
|
392
Ares Management
ARES
$39.5B
| $1.85M | ﹤0.01% |
45,670
| – | – |
|
393
Takeda Pharmaceutical
TAK
$47.6B
| $1M | ﹤0.01% |
55,375
+4,042
| +8% | +$73.3K |
|
394
Barclays
BCS
$73.7B
| $973K | ﹤0.01% |
196,075
+12,641
| +7% | +$62.7K |
|
395
Vertex
VERX
$3.82B
| $816K | ﹤0.01% |
+35,472
| New | +$816K |
|
396
STMicroelectronics
STM
$24.1B
| $815K | ﹤0.01% |
26,629
+2,274
| +9% | +$69.6K |
|
397
Fresenius Medical Care
FMS
$14.5B
| $542K | ﹤0.01% |
12,785
+987
| +8% | +$41.8K |
|
|
NVCN
398
DELISTED
Neovasc Inc.
NVCN
| $529K | ﹤0.01% |
9,884
| – | – |
|
|
AIG.WS
399
DELISTED
American International Group, Inc.
AIG.WS
| $504K | ﹤0.01% |
3,152,474
| – | – |
|
400
iShares Russell 1000 Growth ETF
IWF
$122B
| $437K | ﹤0.01% |
+2,033
| New | +$437K |
|